Insider Selling: NeueHealth, Inc. (NYSE:NEUE) CEO Sells 16,803 Shares of Stock

NeueHealth, Inc. (NYSE:NEUEGet Free Report) CEO George Lawrence Mikan III sold 16,803 shares of the business’s stock in a transaction that occurred on Tuesday, December 17th. The stock was sold at an average price of $4.18, for a total value of $70,236.54. Following the sale, the chief executive officer now owns 83,029 shares of the company’s stock, valued at approximately $347,061.22. This represents a 16.83 % decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this hyperlink.

NeueHealth Stock Performance

NYSE:NEUE traded up $0.01 during mid-day trading on Wednesday, reaching $4.06. 8,840 shares of the company’s stock were exchanged, compared to its average volume of 17,533. The firm has a market capitalization of $33.64 million, a PE ratio of -0.08 and a beta of 0.78. NeueHealth, Inc. has a one year low of $3.99 and a one year high of $16.59. The business’s fifty day simple moving average is $5.15 and its two-hundred day simple moving average is $5.26.

Institutional Inflows and Outflows

Several hedge funds have recently made changes to their positions in the business. NEA Management Company LLC acquired a new stake in NeueHealth during the second quarter worth approximately $14,834,000. Deer Management Co. LLC bought a new stake in shares of NeueHealth during the 2nd quarter valued at $5,436,000. Partners Group Holding AG acquired a new stake in shares of NeueHealth during the 3rd quarter worth $463,000. Renaissance Technologies LLC bought a new position in shares of NeueHealth in the second quarter worth $312,000. Finally, Pathway Capital Management LP acquired a new position in NeueHealth in the second quarter valued at about $61,000. 63.88% of the stock is owned by institutional investors.

Analysts Set New Price Targets

Separately, Royal Bank of Canada decreased their price objective on NeueHealth from $8.00 to $7.00 and set a “sector perform” rating on the stock in a report on Monday, December 9th.

Check Out Our Latest Stock Analysis on NeueHealth

About NeueHealth

(Get Free Report)

NeueHealth, Inc, a healthcare company, provides various healthcare services for health consumers, providers, and payors in the United States. It operates through two segments: NeueCare and NeueSolutions. The NeueCare segment delivers healthcare services to ACA marketplace, medicare, and medicaid through owned and affiliated clinics.

Recommended Stories

Insider Buying and Selling by Quarter for NeueHealth (NYSE:NEUE)

Receive News & Ratings for NeueHealth Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for NeueHealth and related companies with MarketBeat.com's FREE daily email newsletter.